Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ciy Of Hope maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This activity is confined to 1 distinct examiner and 1 distinct art unit. The focus on 1 distinct art unit indicates that the current pending matter is being reviewed within a specific technical specialty. This limits the breadth of the company's active regulatory exposure in the Biotechnology & Pharmaceuticals sector at this time.
FORD, VANESSA L is the busiest examiner for the portfolio, with 1 busiest examiner pending office action. As the total number of pending office actions is 1, this examiner oversees all current Biotechnology & Pharmaceuticals activity for the company. This concentration means that the success of the portfolio's prosecution is dependent on the requirements of this 1 examiner. For the applicant, this creates a situation where the active pipeline is subject to the scrutiny of a single individual. Practitioners should monitor the specific examination style of FORD, VANESSA L to anticipate future prosecution needs.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FORD, VANESSA L | 1 | 38.3% | +38.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270706 | PREVENTION AND TREATMENT OF STEROID-RESISTANT OR GUT GRAFT-VERSUS-HOST DISEASE (GVHD) | FORD, VANESSA L | 40d |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18270706 | PREVENTION AND TREATMENT OF STEROID-RESISTANT OR GUT GRAFT-VERSUS-HOST DISEASE (GVHD) | FORD, VANESSA L | 1674 | §112 | Non-Final OA | 40d | Pending | Jun 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial